Examination of the effect by taking the sodium glucose transporter 2 inhibitor everyday or only when a patient thinks it to be necessary for type 2 diabetes patients controlled inadequately.

Toho University School of Medicine, Division of diabetes, metabolism and endocrinology0 个研究点目标入组 50 人开始时间: 2015年10月6日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1)Type 2 diabetes patients controlled inadequately with 7.0 to 9.9%.
•(2)Patient taking equal or less than three kinds of oral anti-diabete drugs in addition to diet and exercise therapy for 12 weeks or more.
•(3)Patients who does not use human GLP-1 analog or insulin.
•(4)Adalts who are 20 years or older and 75 years or younger.
•(5)Patients who can understand consent brief and other explanation documents having the ability of the agreement about participation in examination.

•(1) Type 1 diabetes mellitus patients or secondary diabetic mellitus.
•(2) Patients who had myocardial infarction within 3 months, or obvious heart failure case.
•(3) Patients who had the past hypersensitivity for the used drug.
•(4) Patients with diabetic ketoacidosis or diabetic coma or risk of diabetic coma.
•(5) Patients with severe liver disease.
•(6) Patients with severe renal disease.
•(7) Patients with severe pancreas disease.
•(8) Patients with hemoglobin (Hb) less than 11 g/dL.
•(9) Patient during cancer treatment
•(10) Patients that the number of the platelets is less than 100,000 /mm3.
•(11) Patients with severe diabetic neuropathy.
•(12) Patients having a proliferative retinopathy.
•(13) Patients with a serious infectious disease or a serious injury.
•(14) Excessive common custom drinker
•(15) A pregnant woman or the woman who may be pregnant.
•(16) In addition, the patients who will be judged inappropriate by an attendant physician.

发起方

Toho University School of Medicine, Division of diabetes, metabolism and endocrinology